CEBPA and acute myeloid leukemia: Although the mutated FLT3/ITD and IDH1 gene incidences in our childhood CK-AML cohort were comparable to those observed in adult counterparts, mutant WT1 and CEBPA gene incidences were higher in our cohort than adult patients (WT1: 13.0% vs. 2.9%; CEBPA: 6.0% vs. 1.5%) [19].